You might want to consider adding this pharmaceutical giant to your portfolio.Eli Lilly (NYSE: LLY) outperformed the broad market S&P 500 index in 2020, but its winning days are not in the rearview mirror. With its strong catalog and pipeline, growing revenues, and a recently boosted dividend, I ...

https://www.fool.com/investing/2021/05/05/why-eli-lilly-is-still-a-top-stock-for-2021/?source=iedfolrf0000001

#fool